OTCQX

Merchants & Marine Bank Receives Preferred Lender Status from the Small Business Administration (SBA)

Retrieved on: 
Monday, July 15, 2024

Merchants & Marine Bank, a subsidiary of Merchants & Marine Bancorp, Inc. (OTCQX: MNMB), announced today that it was granted Preferred Lender Program (PLP) authority by the U.S. Small Business Administration (SBA).

Key Points: 
  • Merchants & Marine Bank, a subsidiary of Merchants & Marine Bancorp, Inc. (OTCQX: MNMB), announced today that it was granted Preferred Lender Program (PLP) authority by the U.S. Small Business Administration (SBA).
  • View the full release here: https://www.businesswire.com/news/home/20240715807351/en/
    “The PLP authority granted by the SBA enables Voyager Lending, a division of Merchants & Marine Bank, to approve most SBA loans in-house, expediting the approval process by eliminating the need for a separate SBA review,” explains Matthew McElveen, President of Voyager Lending, the Government Guaranteed Lending division of Merchants & Marine Bank.
  • “While adhering to all SBA 7(a) Loan Program requirements for originating, closing, servicing, and liquidation, our PLP status empowers us to make local decisions and streamline the lending process for our clients.
  • This translates to faster turnaround times and a more responsive experience for your business.”
    The agreement was made on April 17, 2024, between Merchants & Marine Bank and the U.S. Small Business Administration.

Q.E.P. Co., Inc. Reports Fiscal 2025 First Quarter Financial Results

Retrieved on: 
Monday, July 15, 2024

The Company’s gross profit for the first quarter of fiscal 2025 increased $2.5 million or 12.2% to $22.5 million, from $20.0 million for the first quarter of fiscal 2024.

Key Points: 
  • The Company’s gross profit for the first quarter of fiscal 2025 increased $2.5 million or 12.2% to $22.5 million, from $20.0 million for the first quarter of fiscal 2024.
  • As a percentage of net sales, gross margin was 35.4% for the first quarter of fiscal 2025, as compared to 30.4% for the first quarter of fiscal 2024.
  • Interest income was $0.2 million for the first quarter of fiscal 2025 as compared to interest expense of $0.6 million in the first quarter of fiscal 2024.
  • The provision for income taxes as a percentage of income before taxes was 28% for both the first quarter of fiscal 2025 and the first quarter of fiscal 2024.

Gabelli Multimedia Trust Alerts Common Stock Shareholders to Rights Offering Expiration Date of July 22, 2024

Retrieved on: 
Monday, July 15, 2024

RYE, N.Y., July 15, 2024 (GLOBE NEWSWIRE) -- The Gabelli Multimedia Trust’s (NYSE: GGT) (the “Fund”) transferrable rights offering to acquire additional shares of common stock expires at 5:00 PM Eastern Time on July 22, 2024, unless extended.

Key Points: 
  • RYE, N.Y., July 15, 2024 (GLOBE NEWSWIRE) -- The Gabelli Multimedia Trust’s (NYSE: GGT) (the “Fund”) transferrable rights offering to acquire additional shares of common stock expires at 5:00 PM Eastern Time on July 22, 2024, unless extended.
  • Each shareholder received one transferable right (the “Right”) for each share of common stock held on the record date (June 28, 2024).
  • Four Rights plus $5.00 (the “Subscription Price”) are required to purchase one additional share of common stock (the “Primary Subscription”).
  • Fractional shares of common stock will not be issued upon the exercise of Rights.

Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®

Retrieved on: 
Monday, July 15, 2024

MALVERN, Pa., July 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®.

Key Points: 
  • MALVERN, Pa., July 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®.
  • "The launch of tiopronin delayed-release tablets strengthens our generic product portfolio and underscores our reputation as a reliable supplier."
  • Tiopronin delayed-release tablets are contradicted in patients with hypersensitivity to tiopronin or any other components of tiopronin delayed-release tablets.
  • Tiopronin is released faster from tiopronin delayed-release tablets in the presence of alcohol and the risk for adverse events associated with tiopronin delayed-release tablets when taken with alcohol is unknown.

Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®

Retrieved on: 
Monday, July 15, 2024

MALVERN, Pa., July 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®.

Key Points: 
  • MALVERN, Pa., July 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®.
  • "The launch of tiopronin delayed-release tablets strengthens our generic product portfolio and underscores our reputation as a reliable supplier."
  • Tiopronin delayed-release tablets are contradicted in patients with hypersensitivity to tiopronin or any other components of tiopronin delayed-release tablets.
  • Tiopronin is released faster from tiopronin delayed-release tablets in the presence of alcohol and the risk for adverse events associated with tiopronin delayed-release tablets when taken with alcohol is unknown.

OTC Markets Group Welcomes Danimer Scientific, Inc. to OTCQX

Retrieved on: 
Monday, July 15, 2024

Danimer Scientific, Inc.’s common stock will continue to trade on the New York Stock Exchange.

Key Points: 
  • Danimer Scientific, Inc.’s common stock will continue to trade on the New York Stock Exchange.
  • Danimer Scientific, Inc.’s Warrants begin trading today on OTCQX under the symbol “DNMRW.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com .
  • Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets.
  • To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.

Calibre to Commence an Expanded 100,000 Metre Resource Expansion and Discovery Drill Program Across its Flagship Valentine Gold Mine Property

Retrieved on: 
Monday, July 15, 2024

The 100,000 metre diamond drilling program is in addition to the previously announced 50,000 metre ore control reverse circulation drill program at the Leprechaun and Marathon deposits and the 10,000 metre Winkie/RAB drilling program testing bedrock geology.

Key Points: 
  • The 100,000 metre diamond drilling program is in addition to the previously announced 50,000 metre ore control reverse circulation drill program at the Leprechaun and Marathon deposits and the 10,000 metre Winkie/RAB drilling program testing bedrock geology.
  • The expanded program will include a robust geoscience initiative including a high-definition property wide LiDAR geophysical survey, till sampling and enhanced prospecting to assist with resource expansion and discovery drilling.
  • As we rapidly expand our knowledge base with incoming results, this exploration program is designed to confirm the vast potential of the Valentine mineral system.
  • The 100,000 metre expanded drill program represents the most extensive pure exploration drilling initiative in Valentine’s history.

Meritage Reports Second Quarter 2024 Results; Continued Earnings Growth Ahead

Retrieved on: 
Friday, July 12, 2024

GRAND RAPIDS, Mich., July 12, 2024 (GLOBE NEWSWIRE) -- Meritage Hospitality Group Inc. (OTCQX: MHGU), the nation’s premier franchise operator, today reported financial results for the second quarter ended June 30, 2024.

Key Points: 
  • GRAND RAPIDS, Mich., July 12, 2024 (GLOBE NEWSWIRE) -- Meritage Hospitality Group Inc. (OTCQX: MHGU), the nation’s premier franchise operator, today reported financial results for the second quarter ended June 30, 2024.
  • Earnings from Operations were $7.1 million compared to $8.9 million for the same period last year.
  • Net Earnings were $3.4 million compared to $5.9 million for the same period last year.
  • We remain focused on driving earnings growth through an increase in store-level performance and new unit development, while leveraging our best-in-class operating platform.

New to The Street Announces Episode 580, Six Corporate Interviews, Airing as a Sponsored Program on Bloomberg TV, Saturday, July 13, 2024, at 6:30 PM ET

Retrieved on: 
Friday, July 12, 2024

According to Brody, "Hashing is very clever because if you put information into this little mathematical algorithm, it pops out a number.

Key Points: 
  • According to Brody, "Hashing is very clever because if you put information into this little mathematical algorithm, it pops out a number.
  • And if you change even one letter in any of that information, it turns out to be a completely different number.
  • ANSA readers can click an "ANSAcheck" label that appears with an article to verify the content's authenticity.
  • Viewers, please tune in next time for the newest cybersecurity topic on the "Sekur Privacy & Sekur Security– Weekly Hack" segment.

Danimer Scientific Completes Dividend Distribution of Warrants to Stockholders

Retrieved on: 
Friday, July 12, 2024

Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the completion of a previously announced pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”), as of May 13, 2024 (“Record Date”).

Key Points: 
  • Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the completion of a previously announced pro-rata dividend distribution of warrants (“Dividend Warrants”) to holders of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”), as of May 13, 2024 (“Record Date”).
  • As an example, a stockholder who owns 3,000 shares of Common Stock received 1,000 Dividend Warrants, and a stockholder who owns 1,000 shares of Common Stock received 333 Dividend Warrants.
  • The holders of the Dividend Warrants may exercise the Dividend Warrants by using cash or, during the periods and in the manner specified in the warrant agreement, the Company’s outstanding Convertible Notes.
  • The right of Dividend Warrant holders to exercise their respective Dividend Warrants by delivering Convertible Notes will terminate on the Bonus Share Expiration Date.